Cargando…

Development of Risk Prediction Model for Muscular Calf Vein Thrombosis with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

PURPOSE: This study aims to establish a risk prediction model for muscular calf vein thrombosis (MCVT) in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). METHODS: The research sample consisted of 248 patients with AECOPD and all of them underwent vascular ultrasou...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xiaoman, Li, Xincheng, Xu, Huifen, Zheng, Weili, Wang, Jian, Wang, Wenyu, Li, Senxu, Zhang, Ning, Wang, Yunpeng, Han, Kaiyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375990/
https://www.ncbi.nlm.nih.gov/pubmed/35974801
http://dx.doi.org/10.2147/IJGM.S374777
_version_ 1784768067212935168
author Hu, Xiaoman
Li, Xincheng
Xu, Huifen
Zheng, Weili
Wang, Jian
Wang, Wenyu
Li, Senxu
Zhang, Ning
Wang, Yunpeng
Han, Kaiyu
author_facet Hu, Xiaoman
Li, Xincheng
Xu, Huifen
Zheng, Weili
Wang, Jian
Wang, Wenyu
Li, Senxu
Zhang, Ning
Wang, Yunpeng
Han, Kaiyu
author_sort Hu, Xiaoman
collection PubMed
description PURPOSE: This study aims to establish a risk prediction model for muscular calf vein thrombosis (MCVT) in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). METHODS: The research sample consisted of 248 patients with AECOPD and all of them underwent vascular ultrasounds of both lower limbs in this retrospective study. Univariate analysis and multivariate logistic regression analysis were conducted on factors with significant group differences to screen for the independent risk factors of MCVT. A nomogram to predict the risk of MCVT was constructed and validated with bootstrap resampling. RESULTS: According to the exclusion criteria, 240 patients were included for analysis, divided into the MCVT group (n = 81) and the non-MCVT group (n = 159). Multivariate logistic regression analyses showed that hypertension, elevated MPV, reduced albumin (ALB), elevated D-dimer and bed rest ≥3 days were independent risk factors for MCVT in AECOPD. A nomogram model for predicting AECOPD with MCVT was established based on them. The area under the curve (AUC) of receiver operating characteristic (ROC) curve for the prediction model and the simplified Wells score was 0.784 (95% CI: 0.722–0.847) and 0.659 (95% CI: 0.583–0.735), respectively. The cut-off value and Youden index of prediction model were 0.248 and 0.454, respectively. At the same time, the sensitivity, specificity, positive predictive value, and negative predictive value of the prediction model were 85.9%, 59.5%, 84.6%, and 77.4%, respectively. The sensitivity and specificity of the simplified Wells score were 67.9% and 56.3%, respectively. Validation by the use of bootstrap resampling revealed optimal discrimination and calibration, and the decision analysis curve (DAC) suggested that this prediction model involved high clinical practicability. CONCLUSION: We developed a nomogram that can predict the risk of MCVT for AECOPD patients. This model has the potential to assist clinicians in making treatment recommendations and formulating corresponding prevention measures.
format Online
Article
Text
id pubmed-9375990
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-93759902022-08-15 Development of Risk Prediction Model for Muscular Calf Vein Thrombosis with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Hu, Xiaoman Li, Xincheng Xu, Huifen Zheng, Weili Wang, Jian Wang, Wenyu Li, Senxu Zhang, Ning Wang, Yunpeng Han, Kaiyu Int J Gen Med Original Research PURPOSE: This study aims to establish a risk prediction model for muscular calf vein thrombosis (MCVT) in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). METHODS: The research sample consisted of 248 patients with AECOPD and all of them underwent vascular ultrasounds of both lower limbs in this retrospective study. Univariate analysis and multivariate logistic regression analysis were conducted on factors with significant group differences to screen for the independent risk factors of MCVT. A nomogram to predict the risk of MCVT was constructed and validated with bootstrap resampling. RESULTS: According to the exclusion criteria, 240 patients were included for analysis, divided into the MCVT group (n = 81) and the non-MCVT group (n = 159). Multivariate logistic regression analyses showed that hypertension, elevated MPV, reduced albumin (ALB), elevated D-dimer and bed rest ≥3 days were independent risk factors for MCVT in AECOPD. A nomogram model for predicting AECOPD with MCVT was established based on them. The area under the curve (AUC) of receiver operating characteristic (ROC) curve for the prediction model and the simplified Wells score was 0.784 (95% CI: 0.722–0.847) and 0.659 (95% CI: 0.583–0.735), respectively. The cut-off value and Youden index of prediction model were 0.248 and 0.454, respectively. At the same time, the sensitivity, specificity, positive predictive value, and negative predictive value of the prediction model were 85.9%, 59.5%, 84.6%, and 77.4%, respectively. The sensitivity and specificity of the simplified Wells score were 67.9% and 56.3%, respectively. Validation by the use of bootstrap resampling revealed optimal discrimination and calibration, and the decision analysis curve (DAC) suggested that this prediction model involved high clinical practicability. CONCLUSION: We developed a nomogram that can predict the risk of MCVT for AECOPD patients. This model has the potential to assist clinicians in making treatment recommendations and formulating corresponding prevention measures. Dove 2022-08-10 /pmc/articles/PMC9375990/ /pubmed/35974801 http://dx.doi.org/10.2147/IJGM.S374777 Text en © 2022 Hu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Hu, Xiaoman
Li, Xincheng
Xu, Huifen
Zheng, Weili
Wang, Jian
Wang, Wenyu
Li, Senxu
Zhang, Ning
Wang, Yunpeng
Han, Kaiyu
Development of Risk Prediction Model for Muscular Calf Vein Thrombosis with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
title Development of Risk Prediction Model for Muscular Calf Vein Thrombosis with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
title_full Development of Risk Prediction Model for Muscular Calf Vein Thrombosis with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
title_fullStr Development of Risk Prediction Model for Muscular Calf Vein Thrombosis with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
title_full_unstemmed Development of Risk Prediction Model for Muscular Calf Vein Thrombosis with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
title_short Development of Risk Prediction Model for Muscular Calf Vein Thrombosis with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
title_sort development of risk prediction model for muscular calf vein thrombosis with acute exacerbation of chronic obstructive pulmonary disease
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375990/
https://www.ncbi.nlm.nih.gov/pubmed/35974801
http://dx.doi.org/10.2147/IJGM.S374777
work_keys_str_mv AT huxiaoman developmentofriskpredictionmodelformuscularcalfveinthrombosiswithacuteexacerbationofchronicobstructivepulmonarydisease
AT lixincheng developmentofriskpredictionmodelformuscularcalfveinthrombosiswithacuteexacerbationofchronicobstructivepulmonarydisease
AT xuhuifen developmentofriskpredictionmodelformuscularcalfveinthrombosiswithacuteexacerbationofchronicobstructivepulmonarydisease
AT zhengweili developmentofriskpredictionmodelformuscularcalfveinthrombosiswithacuteexacerbationofchronicobstructivepulmonarydisease
AT wangjian developmentofriskpredictionmodelformuscularcalfveinthrombosiswithacuteexacerbationofchronicobstructivepulmonarydisease
AT wangwenyu developmentofriskpredictionmodelformuscularcalfveinthrombosiswithacuteexacerbationofchronicobstructivepulmonarydisease
AT lisenxu developmentofriskpredictionmodelformuscularcalfveinthrombosiswithacuteexacerbationofchronicobstructivepulmonarydisease
AT zhangning developmentofriskpredictionmodelformuscularcalfveinthrombosiswithacuteexacerbationofchronicobstructivepulmonarydisease
AT wangyunpeng developmentofriskpredictionmodelformuscularcalfveinthrombosiswithacuteexacerbationofchronicobstructivepulmonarydisease
AT hankaiyu developmentofriskpredictionmodelformuscularcalfveinthrombosiswithacuteexacerbationofchronicobstructivepulmonarydisease